Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael H Handler

Showing results (71-80 of 84) with videos related to

Pageof 9
Sort By:
Neuro-Oncology|May 17, 2017
NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymomaAndrea M Griesinger, Davis A Witt, Sydney T Grob, et al.
Neuro-Oncology|July 6, 2019
Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymomaAngela M Pierce, Davis A Witt, Andrew M Donson, et al.
Neuro-Oncology Advances|October 16, 2020
Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomasSydney T Grob, Liana Nobre, Kristen R Campbell, et al.
Neuro-Oncology|June 2, 2021
Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastomaKent A Riemondy, Sujatha Venkataraman, Nicholas Willard, et al.
Elife|January 18, 2017
Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumorsJean M Mulcahy Levy, Shadi Zahedi, Andrea M Griesinger, et al.
Journal of Neuropathology and Experimental Neurology|September 2, 2017
Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous CraniopharyngiomaAndrew M Donson, John Apps, Andrea M Griesinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial EpendymomaThomas E Merchant, Anne E Bendel, Noah D Sabin, et al.
Neuro-Oncology|December 21, 2025
Phase 3 randomized trial of post-irradiation chemotherapy in patients with newly diagnosed ependymoma, a report from the Children's Oncology GroupAmy A Smith, Arzu Onar-Thomas, Shelly Lensing, et al.
Scientific Reports|October 10, 2020
Robust deep learning classification of adamantinomatous craniopharyngioma from limited preoperative radiographic imagesEric W Prince, Ros Whelan, David M Mirsky, et al.
Acta Neuropathologica Communications|May 15, 2020
Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targetsEric Prince, Ros Whelan, Andrew Donson, et al.
Pageof 9

Showing results (71-80 of 84) with videos related to

Sort By:
Pageof 9
Neuro-Oncology|May 17, 2017
NF-κB upregulation through epigenetic silencing of LDOC1 drives tumor biology and specific immunophenotype in Group A ependymomaAndrea M Griesinger, Davis A Witt, Sydney T Grob, et al.
Neuro-Oncology|July 6, 2019
Establishment of patient-derived orthotopic xenograft model of 1q+ posterior fossa group A ependymomaAngela M Pierce, Davis A Witt, Andrew M Donson, et al.
Neuro-Oncology Advances|October 16, 2020
Clinical and molecular characterization of a multi-institutional cohort of pediatric spinal cord low-grade gliomasSydney T Grob, Liana Nobre, Kristen R Campbell, et al.
Neuro-Oncology|June 2, 2021
Neoplastic and immune single-cell transcriptomics define subgroup-specific intra-tumoral heterogeneity of childhood medulloblastomaKent A Riemondy, Sujatha Venkataraman, Nicholas Willard, et al.
Elife|January 18, 2017
Autophagy inhibition overcomes multiple mechanisms of resistance to BRAF inhibition in brain tumorsJean M Mulcahy Levy, Shadi Zahedi, Andrea M Griesinger, et al.
Journal of Neuropathology and Experimental Neurology|September 2, 2017
Molecular Analyses Reveal Inflammatory Mediators in the Solid Component and Cyst Fluid of Human Adamantinomatous CraniopharyngiomaAndrew M Donson, John Apps, Andrea M Griesinger, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 28, 2019
Conformal Radiation Therapy for Pediatric Ependymoma, Chemotherapy for Incompletely Resected Ependymoma, and Observation for Completely Resected, Supratentorial EpendymomaThomas E Merchant, Anne E Bendel, Noah D Sabin, et al.
Neuro-Oncology|December 21, 2025
Phase 3 randomized trial of post-irradiation chemotherapy in patients with newly diagnosed ependymoma, a report from the Children's Oncology GroupAmy A Smith, Arzu Onar-Thomas, Shelly Lensing, et al.
Scientific Reports|October 10, 2020
Robust deep learning classification of adamantinomatous craniopharyngioma from limited preoperative radiographic imagesEric W Prince, Ros Whelan, David M Mirsky, et al.
Acta Neuropathologica Communications|May 15, 2020
Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targetsEric Prince, Ros Whelan, Andrew Donson, et al.
Pageof 9